Shanghai, China

Jiajian Liu

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2024

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Jiajian Liu: A Pioneer in Antibody Innovations

Introduction

Jiajian Liu, a distinguished inventor based in Shanghai, China, has made remarkable contributions to the field of antibody development. With a total of five patents to his name, Liu's work focuses on innovative therapies aimed at treating various forms of cancer through targeted antibody technology.

Latest Patents

Liu's latest patents illustrate his cutting-edge research in the realm of antibodies. One of his notable innovations includes an antibody that targets CLDN18.2. This antibody comprises specific variable light (VL) and variable heavy (VH) chain sequences, allowing for precise targeting of cancer cells. Additionally, he developed a bispecific antibody and a conjugated antibody-drug complex aimed at improving treatment efficacy. Another significant patent involves an anti-c-Met antibody, designed for therapeutic applications alongside a cytotoxic drug conjugate, offering new hope for cancer treatments.

Career Highlights

Throughout his career, Jiajian Liu has collaborated with prominent companies in the pharmaceutical sector, specifically Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His expertise and innovative approach have been pivotal in advancing therapeutic options within these organizations.

Collaborations

Liu’s work has frequently involved collaboration with talented professionals, including colleagues Lianshan Zhang and Piaoyang Sun. Their collective efforts have fostered an environment of innovation, enabling the development of groundbreaking antibody technologies.

Conclusion

Jiajian Liu's contributions to antibody research and development position him as a significant figure in the field of biomedicine. His innovative patents not only showcase his expertise but also represent the potential for new therapeutic approaches in cancer treatment. As he continues to push the boundaries of scientific discovery, Liu remains a vital player in the advancement of medical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…